Compare GAUZ & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GAUZ | NDRA |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 8.1M |
| IPO Year | 2019 | 2016 |
| Metric | GAUZ | NDRA |
|---|---|---|
| Price | $0.39 | $5.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $11.50 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 11.9M | 34.1K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.59 | N/A |
| Revenue Next Year | $59.03 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $2.96 |
| 52 Week High | $7.07 | $9.83 |
| Indicator | GAUZ | NDRA |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 59.09 |
| Support Level | $0.36 | $4.35 |
| Resistance Level | $0.50 | $6.08 |
| Average True Range (ATR) | 0.06 | 0.57 |
| MACD | -0.00 | 0.15 |
| Stochastic Oscillator | 51.23 | 57.96 |
Gauzy Ltd is a fully integrated light and vision control company. Its products products include suspended particle device, or SPD, and liquid crystal, or LC, materials for smart glass applications, and AI-powered advanced driver assistance systems, or ADAS, solutions including camera monitoring systems, or CMS. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.